- Home
- DHY vs LFMD Comparison
DHY vs LFMD Comparison
Compare DHY & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DHY | LFMD |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.4M | 218.1M |
| IPO Year | 1998 | 2012 |
Fundamental Metrics
Financial Performance| Metric | DHY | LFMD |
|---|---|---|
| Price | $1.70 | $2.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | ★ 743.9K | 597.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,468,578.00 |
| Revenue This Year | N/A | $17.52 |
| Revenue Next Year | N/A | $18.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $1.69 | $2.60 |
| 52 Week High | $2.13 | $7.32 |
Technical Indicators
Market Signals| Indicator | DHY | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.48 | 32.27 |
| Support Level | N/A | $2.66 |
| Resistance Level | $2.05 | $3.41 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 20.00 | 4.17 |
Price Performance
Historical ComparisonAbout DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.